fr   en
Fundraisings
Select a company :
Select an investor :
Choose date:
[<<]      «      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11      »      [23]
Date Company Amount Investors Planned use / Other
2010-04-23 AB Science (France) €16.5 million (increased to €31.6 million post exercise in full of the over-allotment option)   See details
2010-04-21 Affitech (Denmark) (€20.3 million Trans Nova Investments Limited (Cyprus) See details
2010-04-16 4SC (Germany) Nexigen (Germany) €1.4 million Federal Ministry of Education and Research (BMBF - Germany) See details
2010-04-15 Neovacs (France) €10 million   See details
2010-04-15 Novagali Pharma (France) € 7.4 million OSEO (France) See details
2010-04-08 Galapagos (Belgium) €2.1 million employees and management See details
2010-04-06 Mologen (Germany) € 280,000 Federal Ministry of Education and Research (Germany)
See details
2010-03-31 Diamyd Medical (Sweden) MSEK 35 (€ 36 million)   See details
2010-03-31 Agennix (Germany) € 9.8 million   See details
2010-03-23 Aquapharm (UK) £4.2 million Aescap Venture
Tate & Lyle Ventures
Highlands and Islands Enterprise
NESTA
See details
2010-03-15 Genticel (France) €13.1 million AGF Private Equity (France)
IRDI (Institut Régional de Développement Industriel) (France)
Amundi Private Equity Funds
InnoBio fund (France)
Edmond de Rothschild Investment Partners (EdRIP) (France)
Other previous investors
See details
2010-03-15 Ablynx (Belgium) €50 million   See details
2010-03-09 Antisense Pharma (Germany) € 13 million MIG Fonds (Germany)
GA Global Asset Fund (Germany)
private investors
company’s management
See details
2010-03-08 Epigenomics (Germany) up to €14,7 million   See details
2010-03-04 Medgenics (Israel-USA) £0.726 million (€0.8 million)   See details
[<<]      «      1   |   2   |   3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11      »      [23]